HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

The First Circuit upheld a district court’s pause of the controversial pilot on Wednesday. It’s a setback for the Trump ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal ...

The drug giant says an Eighth Circuit ruling last year in a case from Minnesota should block a similar law in Missouri.

On August 1, 2025, the Health Resources and Services Administration (“HRSA”) issued a Notice announcing the launch of the 340B Rebate Model Pilot Program (“Pilot Program”), that would dramatically ...

The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...

In May 2025, Gov. Jared Polis signed Senate Bill 71 into law, dramatically expanding Colorado’s participation in the 340B ...

In a move that will fundamentally change how the 340B Drug Pricing Program (“340B Program”) operates for a subset of medications, HRSA’s Office of Pharmacy Affairs (“OPA”) opted late last week to ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

Created in 1992, the 340B Drug Pricing Program is a U.S. federal government program intended to give safety net providers—those that organize and deliver a significant level of both healthcare and ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...